Companies
/Healthcare
Kamada Ltd
$8.20
▼ $0.18 (−2.15%) today
Markets open · 12:54pm ET
Today · % change
Fundamentals
Market Cap
$483.5M
P/E Ratio
22.7
Dividend Yield
1.97%
Profit Margin
11.6%
Revenue (TTM)
$191.8M
EPS (TTM)
$0.37
52-Week Range
$6 – $9
Street Target
$13.50
About Kamada
Kamada Ltd. is an Israel-based biopharmaceutical company specializing in the development and production of plasma-derived protein therapeutics. The company's diverse product portfolio includes treatments for immune disorders, liver transplants, varicella prophylaxis, and Alpha-1 Antitrypsin Deficiency (AATD), among others. Kamada also offers a range of products for conditions such as asthma, allergic rhinitis, hemophilia, and prostate cancer. With a global reach, Kamada markets its innovative therapies through strategic partnerships and distributors worldwide, focusing on improving patient care and outcomes.